Fig. 2: Longitudinal analysis of SHIV antibody levels.
From: SHIV remission in macaques with early treatment initiation and ultra long-lasting antiviral activity
SHIV plasma IgG levels against gp140, gp130, gp36, gp41, p66, nef, and p27 were measured longitudinally using a Bio-Plex assay. Light blue lines denote the mean fluorescent intensity (MFI) for each treated animal; dark blue line indicates the median MFI values. Two untreated controls (macaques 09–19 and 10–87) are shown in red. Treatment in the early ART (eART) animals was initiated 5 to 6 days after infection. The shaded blue area represents the period of treatment with FTC/TAF/CAB LA/RPV LA (months 1-6) and CAB LA/RPV LA (months 6–12). The horizontal dotted line denotes cutoff values for each analyte. Source data are provided as a Source Data file.
